Novo Nordisk A/S

Equities

NOVO B

DK0062498333

Pharmaceuticals

Market Closed - Nasdaq Copenhagen 16:20:00 04/07/2024 BST 5-day change 1st Jan Change
970 DKK +0.26% Intraday chart for Novo Nordisk A/S -3.67% +38.95%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
ETF of the week: Investing in strong trends with the momentum theme Our Logo
NOVO NORDISK : Deutsche Bank remains its Buy rating ZD
AlphaValue/Baader Europe Upgrades Novo Nordisk to Buy from Add, Lifts PT MT
Sector Update: Health Care Stocks Fall in Afternoon Trading MT
Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows MT
Top Midday Stories: Southwest Board Approves Shareholder Rights Plan; National Amusements Agrees to Preliminary Deal to Sell Paramount to Skydance; Ozempic, Wegovy Linked to Blinding Eye Condition, Study Says MT
Ozempic, Wegovy Linked to Risk of Blinding Eye Condition, Study Shows MT
Global markets live: Eli Lilly, Apple, Walmart, Shell, Rio Tinto... Our Logo
Wegovy, Ozempic linked with sight-threatening eye disorder in study RE
European Equities Traded in the US as American Depositary Receipts Trend Higher in Wednesday Trading MT
Ozempic, Wegovy Linked to Higher Risk of Blinding Eye Condition, Study Says MT
NOVO NORDISK : Berenberg reiterates its Neutral rating ZD
NOVO NORDISK : Buy rating from Goldman Sachs ZD
US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices MT
US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices MT
Tesla, megacaps drive S&P 500, Nasdaq higher; rates outlook in focus RE
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say MT
Top Midday Stories: Tesla, GM Report Vehicle Deliveries; Biden, Sanders Say Novo Nordisk, Eli Lilly Charge 'Unconscionably' High Prices; Warner Bros. Interested in Deal With Paramount MT
US President Calls Out Eli Lilly, Novo Nordisk Over High Drug Prices MT
Wall St edges lower as Powell signals caution; Tesla jumps after delivery data RE
US FDA warns website over unlawful sale of weight-loss drugs RE
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday MT
Wall St set for lower open as megacaps retreat with jobs data, Powell in focus RE
Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say MT
Biden says Novo Nordisk must cut prices of diabetes, weight loss drugs RE
Chart Novo Nordisk A/S
More charts
Novo Nordisk A/S specializes in the design, manufacture and marketing of pharmaceutical products. Net sales break down by family of products as follows: - diabetes and obesity treatment products (92.6%); - rare disease treatment products (7.4%): intended for the treatment of haemophilia, blood disorders, hormonal disorders, etc. Net sales are distributed geographically as follows: Europe/Middle East/Africa (21.9%), the United States (54.9%), North America (3.9%), China (7.2%) and other (12.1%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
26
Last Close Price
967.5 DKK
Average target price
952.2 DKK
Spread / Average Target
-1.59%
Consensus
  1. Stock Market
  2. Equities
  3. NOVO B Stock
  4. News Novo Nordisk A/S
  5. Novo Nordisk, Eli Lilly Charging 'Unconscionably' High Prices, Biden, Sanders Say